Cargando…
Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles
We previously reported that siRNA delivery to the brain is improved by the nose-to-brain delivery route and by conjugation with polyethylene glycol-polycaprolactone (PEG-PCL) polymer micelles and the cell-penetrating peptide, Tat (PEG-PCL-Tat). In this study, we evaluated the nose-to-brain delivery...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781507/ https://www.ncbi.nlm.nih.gov/pubmed/31540164 http://dx.doi.org/10.3390/pharmaceutics11090478 |
_version_ | 1783457388772196352 |
---|---|
author | Kanazawa, Takanori Kurano, Takumi Ibaraki, Hisako Takashima, Yuuki Suzuki, Toyofumi Seta, Yasuo |
author_facet | Kanazawa, Takanori Kurano, Takumi Ibaraki, Hisako Takashima, Yuuki Suzuki, Toyofumi Seta, Yasuo |
author_sort | Kanazawa, Takanori |
collection | PubMed |
description | We previously reported that siRNA delivery to the brain is improved by the nose-to-brain delivery route and by conjugation with polyethylene glycol-polycaprolactone (PEG-PCL) polymer micelles and the cell-penetrating peptide, Tat (PEG-PCL-Tat). In this study, we evaluated the nose-to-brain delivery of siRNA targeting TNF-α (siTNF-α) conjugated with PEG-PCL-Tat to investigate its therapeutic effects on a transient middle cerebral artery occlusion (t-MCAO) rat model of cerebral ischemia-reperfusion injury. Intranasal treatment was provided 30 min after infarction induced via suturing. Two hours after infarction induction, the suture was removed, and blood flow was released. At 22 h post-reperfusion, we assessed the infarcted area, TNF-α production, and neurological score to determine the therapeutic effects. The infarcted area was observed over a wide range in the untreated group, whereas shrinkage of the infarcted area was observed in rats subjected to intranasal administration of siTNF-α with PEG-PCL-Tat micelles. Moreover, TNF-α production and neurological score in rats treated by intranasal administration of siTNF-α with PEG-PCL-Tat micelles were significantly lower than those in untreated and naked siTNF-α-treated rats. These results indicate that nose-to-brain delivery of siTNF-α conjugated with PEG-PCL-Tat micelles alleviated the symptoms of cerebral ischemia-reperfusion injury. |
format | Online Article Text |
id | pubmed-6781507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67815072019-10-30 Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles Kanazawa, Takanori Kurano, Takumi Ibaraki, Hisako Takashima, Yuuki Suzuki, Toyofumi Seta, Yasuo Pharmaceutics Article We previously reported that siRNA delivery to the brain is improved by the nose-to-brain delivery route and by conjugation with polyethylene glycol-polycaprolactone (PEG-PCL) polymer micelles and the cell-penetrating peptide, Tat (PEG-PCL-Tat). In this study, we evaluated the nose-to-brain delivery of siRNA targeting TNF-α (siTNF-α) conjugated with PEG-PCL-Tat to investigate its therapeutic effects on a transient middle cerebral artery occlusion (t-MCAO) rat model of cerebral ischemia-reperfusion injury. Intranasal treatment was provided 30 min after infarction induced via suturing. Two hours after infarction induction, the suture was removed, and blood flow was released. At 22 h post-reperfusion, we assessed the infarcted area, TNF-α production, and neurological score to determine the therapeutic effects. The infarcted area was observed over a wide range in the untreated group, whereas shrinkage of the infarcted area was observed in rats subjected to intranasal administration of siTNF-α with PEG-PCL-Tat micelles. Moreover, TNF-α production and neurological score in rats treated by intranasal administration of siTNF-α with PEG-PCL-Tat micelles were significantly lower than those in untreated and naked siTNF-α-treated rats. These results indicate that nose-to-brain delivery of siTNF-α conjugated with PEG-PCL-Tat micelles alleviated the symptoms of cerebral ischemia-reperfusion injury. MDPI 2019-09-15 /pmc/articles/PMC6781507/ /pubmed/31540164 http://dx.doi.org/10.3390/pharmaceutics11090478 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kanazawa, Takanori Kurano, Takumi Ibaraki, Hisako Takashima, Yuuki Suzuki, Toyofumi Seta, Yasuo Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles |
title | Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles |
title_full | Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles |
title_fullStr | Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles |
title_full_unstemmed | Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles |
title_short | Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles |
title_sort | therapeutic effects in a transient middle cerebral artery occlusion rat model by nose-to-brain delivery of anti-tnf-alpha sirna with cell-penetrating peptide-modified polymer micelles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781507/ https://www.ncbi.nlm.nih.gov/pubmed/31540164 http://dx.doi.org/10.3390/pharmaceutics11090478 |
work_keys_str_mv | AT kanazawatakanori therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles AT kuranotakumi therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles AT ibarakihisako therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles AT takashimayuuki therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles AT suzukitoyofumi therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles AT setayasuo therapeuticeffectsinatransientmiddlecerebralarteryocclusionratmodelbynosetobraindeliveryofantitnfalphasirnawithcellpenetratingpeptidemodifiedpolymermicelles |